These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37661652)

  • 1. Predictive factors of development of dysthyroid optic neuropathy among individuals with thyroid-eye disease.
    Kemchoknatee P; Thongsawangchai N; Srisombut T; Tangon D; Chantra S
    Eur J Ophthalmol; 2024 May; 34(3):834-842. PubMed ID: 37661652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic Nerve Head Vessel Density Changes from Graves' Disease without TED to TED Dysthyroid Optic Neuropathy: Does Optic Nerve Head Ischemia Play a Role?
    Abdolalizadeh P; Kashkouli MB; Moradpasandi F; Falavarjani KG; Mirshahi R; Akbarian S
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):250-257. PubMed ID: 34593713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
    Kemchoknatee P; Tangon D; Srisombut T
    BMC Ophthalmol; 2023 Jan; 23(1):32. PubMed ID: 36690985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.
    Park KA; Kim YD; In Woo K; Kee C; Han JC
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1617-1624. PubMed ID: 27169807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
    McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
    Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.
    Starks VS; Reinshagen KL; Lee NG; Freitag SK
    Orbit; 2020 Apr; 39(2):77-83. PubMed ID: 31057005
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
    Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
    Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics of dysthyroid optic neuropathy].
    Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
    Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.
    Deng Z; Chen L; Tan J; Wang S; Liu D; Wang J; Jiang C; Yang J; Xu B
    Dis Markers; 2021; 2021():9964232. PubMed ID: 34113406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysthyroid optic neuropathy: evaluation and management.
    Dolman PJ
    J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sight-Threatening Thyroid Eye Disease: Role of Diabetes Mellitus and Interaction with Other Risk Factors.
    Rath S; Pattnaik M; Tripathy D; Mohapatra S; Panigrahy B; Ali MH
    Ophthalmic Plast Reconstr Surg; 2021 Jul-Aug 01; 37(4):352-360. PubMed ID: 33060509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of optic nerve length and tortuosity in thyroid eye disease.
    Ugradar S; Rootman DB
    Can J Ophthalmol; 2019 Oct; 54(5):611-614. PubMed ID: 31564353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Related Changes in the Clinical Phenotype of Compressive Optic Neuropathy in Thyroid Eye Disease.
    Campbell AA; Nanda T; Oropesa S; Kazim M
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):238-242. PubMed ID: 30234838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients.
    Vermot-Desroches V; Thia-Soui-Tchong K; Raymond P; Filip A; Orgiazzi J; Jouanneau E; Froment Tilikete C; Borson-Chazot F; Manet R; Abeillon Du Payrat J
    Ann Endocrinol (Paris); 2023 Aug; 84(4):430-439. PubMed ID: 37086950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Experience With Teprotumumab in Patients With Dysthyroid Optic Neuropathy.
    Tamhankar MA; Pradeep T; Chen Y; Briceño CA
    J Neuroophthalmol; 2024 Mar; 44(1):74-79. PubMed ID: 37751310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy.
    Lu TJ; Amarikwa L; Sears CM; Kossler AL
    Curr Neurol Neurosci Rep; 2022 Jun; 22(6):313-325. PubMed ID: 35614367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
    Pascual-Camps I; Molina-Pallete R; Bort-Martí MA; Todolí J; España-Gregori E
    Orbit; 2018 Dec; 37(6):450-453. PubMed ID: 29420104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.
    Mensah A; Vignal-Clermont C; Mehanna C; Morel X; Galatoire O; Jacomet PV; Morax S
    Orbit; 2009; 28(6):354-62. PubMed ID: 19929659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Changes in Optic Nerve after Orbital Decompression Surgery for Thyroid Eye Disease and Case Reports of Ischemic Optic Neuropathy.
    Hsia Y; Hsiao CC; Wei YH; Lai IW; Lin CW; Liao SL
    Biomed Res Int; 2022; 2022():4808194. PubMed ID: 35265712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.